Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors

Antiviral Res. 2020 Jun:178:104781. doi: 10.1016/j.antiviral.2020.104781. Epub 2020 Mar 29.

Abstract

Enteroviruses (EV) are a group of positive-strand RNA (+RNA) viruses that include many important human pathogens (e.g. poliovirus, coxsackievirus, echovirus, numbered enteroviruses and rhinoviruses). Fluoxetine was identified in drug repurposing screens as potent inhibitor of enterovirus B and enterovirus D replication. In this paper we are reporting the synthesis and the antiviral effect of a series of fluoxetine analogues. The results obtained offer a preliminary insight into the structure-activity relationship of its chemical scaffold and confirm the importance of the chiral configuration. We identified a racemic fluoxetine analogue, 2b, which showed a similar antiviral activity compared to (S)-fluoxetine. Investigating the stereochemistry of 2b revealed that the S-enantiomer exerts potent antiviral activity and increased the antiviral spectrum compared to the racemic mixture of 2b. In line with the observed antiviral effect, the S-enantiomer displayed a dose-dependent shift in the melting temperature in thermal shift assays, indicative for direct binding to the recombinant 2C protein.

Keywords: 2C Inhibitors; Enterovirus; Fluoxetine; Thermal shift assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology*
  • Carrier Proteins / antagonists & inhibitors*
  • Carrier Proteins / metabolism
  • Cell Line
  • Cytopathogenic Effect, Viral / drug effects
  • Enterovirus B, Human / drug effects*
  • Enterovirus B, Human / physiology
  • Enterovirus D, Human / drug effects*
  • Enterovirus D, Human / physiology
  • Fluoxetine / analogs & derivatives*
  • Fluoxetine / chemistry
  • Fluoxetine / metabolism
  • Fluoxetine / pharmacology
  • HeLa Cells
  • Humans
  • Stereoisomerism
  • Structure-Activity Relationship
  • Viral Nonstructural Proteins / antagonists & inhibitors*
  • Viral Nonstructural Proteins / metabolism

Substances

  • Antiviral Agents
  • Carrier Proteins
  • Viral Nonstructural Proteins
  • Fluoxetine
  • 2C protein, viral